Natural Wound Healing Agent
Raepenol™️
R&D Project Supported by Korean Ministry of SMEs and Startup
Safe Wound Healing Agent Based on Natural Complexes
Relieves Itching and Inflammation
Normal Epidermis
Untreated
Commercial Ointment
Treated
(A Company)
(A Company)
Commercial Ointment
Treated
(B Company)
(B Company)
Raepenol™️ Treated
The histologic analysis by H&E staining to show the repaired keratinized stratified squamous epithelium, epidermis and dermis.
Normal Epidermis
Untreated
Commercial Ointment
Treated
(A Company)
(A Company)
Commercial Ointment
Treated
(B Company)
(B Company)
Raepenol™️ Treated
Regeneration of collagen fiber in the epidermis were stained by Masson’s trichrome stain
Skin Regeneration by Restoring the Dermis and Collagen in the Wounded Area
Patent Registration in Korea and the United States (applied in Canada) Technology Product
(Patent No. KR10-2328178,
US11337842B2, CA3143557)
US11337842B2, CA3143557)
Products for Consumer Needs
Scheduled to launch in 2024
Preclinical Completion
